Published in J Card Fail on August 01, 2003
Quality still doesn't pay in heart failure management. J Card Fail (2003) 0.75
Management programmes for heart failure. Heart (2004) 0.75
Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation (2007) 2.14
Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol (2007) 1.92
Prospective analysis of LDL-C goal achievement and self-reported medication adherence among statin users in primary care. Clin Ther (2011) 1.58
Aspirin use in heart failure: is low-dose therapy associated with mortality and morbidity benefits in a large community population? Circ Heart Fail (2014) 1.40
MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure. Eur J Heart Fail (2015) 1.24
Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover. Eur J Heart Fail (2009) 1.12
The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients. J Card Fail (2007) 1.02
Outpatient intravenous diuretic therapy; potential for marked reduction in hospitalisations for acute decompensated heart failure. Eur J Heart Fail (2008) 0.96
Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis? Eur J Heart Fail (2005) 0.96
Decompensation of chronic heart failure associated with pregabalin in patients with neuropathic pain. J Card Fail (2007) 0.94
Quality of life predicts outcome in a heart failure disease management program. Int J Cardiol (2008) 0.94
Multiple neurohumoral modulating agents in systolic dysfunction heart failure: are we lowering blood pressure too much? J Card Fail (2008) 0.93
Heart failure management: multidisciplinary care has intrinsic benefit above the optimization of medical care. J Card Fail (2002) 0.90
Nitric oxide-matrix metaloproteinase-9 interactions: biological and pharmacological significance--NO and MMP-9 interactions. Biochim Biophys Acta (2014) 0.89
Progression of preserved systolic function heart failure to systolic dysfunction -- a natural history study. Int J Cardiol (2006) 0.83
Attenuation of monocyte chemotaxis--a novel anti-inflammatory mechanism of action for the cardio-protective hormone B-type natriuretic peptide. J Cardiovasc Transl Res (2013) 0.83
Are beta2-agonists responsible for increased mortality in heart failure? Eur J Heart Fail (2011) 0.79
Fluid restriction in the management of decompensated heart failure: no impact on time to clinical stability. J Card Fail (2007) 0.79
Modest elevation in BNP in asymptomatic hypertensive patients reflects sub-clinical cardiac remodeling, inflammation and extracellular matrix changes. PLoS One (2012) 0.79
Specialist nurse supervised in-hospital titration to target dose ACE inhibitor--is it safe and feasible in a community heart failure population? Eur J Cardiovasc Nurs (2003) 0.77
Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide. Clin Ther (2011) 0.77
Extracellular matrix sub-types and mechanical stretch impact human cardiac fibroblast responses to transforming growth factor beta. Connect Tissue Res (2014) 0.76
Improvement but no cure of left ventricular systolic dysfunction in treated heart failure patients. Eur J Heart Fail (2007) 0.76
Differential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin. Br J Pharmacol (2012) 0.76
Mechanisms of aggregation inhibition by aspirin and nitrate-aspirin prodrugs in human platelets. J Pharm Pharmacol (2011) 0.76
Role of Monitoring Devices in Preventing Heart Failure Admissions. Curr Heart Fail Rep (2015) 0.75
Disease management programs for heart failure: not just for the 'sick' heart failure population. Eur J Heart Fail (2006) 0.75
The St Vincent's potentially inappropriate medicines study: development of a disease-specific consensus list and its evaluation in ambulatory heart failure care. Eur J Heart Fail (2014) 0.75
B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors and their therapies. Observations from the STOP-HF (St. Vincent's Screening TO Prevent Heart Failure) study. Clin Chem Lab Med (2011) 0.75
Multidisciplinary care of heart failure: what have we learned and where can we improve? Eur J Cardiovasc Nurs (2003) 0.75
Need and evolution of need for device therapy in a community heart failure population. Eur J Heart Fail (2008) 0.75